Corton Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,179
Closed -$229K 514
2024
Q2
$229K Buy
+6,179
New +$229K 0.12% 301